4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-059247
Chief R&D Officer sold 29,618 shares at $16.93 ($501,433)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zalevsky Jonathan Chief R&D Officer | 2020-11-16 | Sale | −29,618 | $16.93 | $501,433 | 266,697 | D |
| Open-market sales · 29,618 sh · avg $16.93 · $501,433 | |||||||
Loading xslF345X03/doc4.xml…